Selective Inhibition of USP7

  • Menard, Robert
  • Sulea, Traian
Open PDF
Publication date
April 2012
Publisher
Elsevier Ltd.

Abstract

The deubiquitinating enzyme USP7 is an emerging oncology and antiviral target. Reverdy et al., in this issue of Chemistry & Biology, disclose the first small-molecule inhibitor selective for USP7, which recapitulates its knockdown in cancer cells and hence demonstrates the therapeutic feasibility of USP7 inhibitors

Extracted data

We use cookies to provide a better user experience.